Comparative analysis of efficacy and pain management in acute respiratory failure: a systematic review and meta-analysis

Background: This meta-analysis aims to evaluate the efficacy and pain management outcomes of various interventions in patients with acute respiratory failure (ARF) in intensive care settings. Methods: To identify randomized controlled trials (RCTs) evaluating the effectiveness and outcomes of interventions for ARF in pain management, a thorough search was performed on the Ovid Medline database until August 2024. The quality of the studies was evaluated following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Effect sizes and 95% confidence intervals (CI) were computed utilizing a random-effects model, while heterogeneity was evaluated using I2 statistics. Results: A total of 3000 participants from five studies were analyzed. The interventions demonstrated varying levels of efficacy and pain management outcomes, with overall significant efficacy (effect size 1.40, 95% CI: 1.05 to 1.87). Nevertheless, the results of pain management exhibited an overall tendency towards negative effect sizes, suggesting difficulties in effectively managing pain through the various interventions. The level of heterogeneity was deemed moderate (I2 = 26%), highlighting variations in research methodologies and the characteristics of the patient cohorts. Conclusion: This meta-analysis indicates that while certain interventions significantly improve clinical outcomes in ARF patients, pain management remains a challenge. The results indicate a necessity for holistic strategies that blend effectiveness with patient well-being. Future studies should prioritize refining treatments to enhance both effectiveness and pain relief in the management of ARF. The INPLASY Registration: Our meta-analysis protocol was registered in INPLASY (registration number: INPLASY2024100058) and can be found at https://inplasy.com/inplasy-2024-10-0058/.

Acute respiratory failure (ARF); Efficacy; Pain management; Randomized controlled trials; Meta-analysis

[1] Wilson ME, Mittal A, Karki B, Dobler CC, Wahab A, Curtis JR, et al. Do-not-intubate orders in patients with acute respiratory failure: a systematic review and meta-analysis. Intensive Care Medicine. 2020; 46: 36–45.

[2] Ali F, Sweeney DA. In pursuit of microbiome-based therapies for acute respiratory failure. American Journal of Respiratory and Critical Care Medicine. 2020; 202: 1616–1618.

[3] Kim HJ, Jeong J, Moon HJ, Lee HJ, Jeong D, Shin TY, et al. Prediction of high-flow nasal cannula failure in patients with acute respiratory failure by measuring the cross-sectional area of the diaphragmatic crus and ROX index. Signa Vitae. 2023; 19: 169–177.

[4] Morris PE, Berry MJ, Files DC, Thompson JC, Hauser J, Flores L, et al. Standardized rehabilitation and hospital length of stay among patients with acute respiratory failure: a randomized clinical trial. JAMA. 2016; 315: 2694–2702.

[5] Erdem SB, Genel F, Nacaroglu HT, Karaman S, Karkıner CSU, Sürücü M, et al. CD4+CD25+CD127loFOXP3+ cell in food allergy: does it predict anaphylaxis? Allergologia et Immunopathologia. 2023; 51: 8–14.

[6] Coudroy R, Frat JP, Ehrmann S, Pène F, Decavèle M, Terzi N, et al.; FLORALI-IM study group and the REVA Research Network. High-flow nasal oxygen alone or alternating with non-invasive ventilation in critically ill immunocompromised patients with acute respiratory failure: a randomised controlled trial. The Lancet Respiratory Medicine. 2022; 10: 641–649.

[7] Akhigbe P, Osagie E, Obuekwe O, Omoigberale A, Richards VP, Coker MO, et al. Prevalence and associated factors of enamel developmental defects among Nigerian children with perinatal HIV exposure. Journal of Clinical Pediatric Dentistry. 2023; 47: 1–9.

[8] Cuquemelle E, Pham T, Papon J, Louis B, Danin P, Brochard L. Heated and humidified high-flow oxygen therapy reduces discomfort during hypoxemic respiratory failure. Respiratory Care. 2012; 57: 1571–1577.

[9] Dequin PF, Heming N, Meziani F, Plantefève G, Voiriot G, Badié J, et al.; CAPE COVID Trial Group and the CRICS-TriGGERSep Network. Effect of hydrocortisone on 21-day mortality or respiratory support among critically ill patients with COVID-19: a randomized clinical trial. JAMA. 2020; 324: 1298–1306.

[10] Stewart LA, Clarke M, Rovers M, Riley RD, Simmonds M, Stewart G, et al.; PRISMA-IPD Development Group. Preferred reporting items for systematic review and meta-analyses of individual participant data: the PRISMA-IPD statement. JAMA. 2015; 313: 1657–1665.

[11] Curley MA, Wypij D, Watson RS, Grant MJ, Asaro LA, Cheifetz IM, et al.; RESTORE Study Investigators and the Pediatric Acute Lung Injury and Sepsis Investigators Network. Protocolized sedation vs. usual care in pediatric patients mechanically ventilated for acute respiratory failure: a randomized clinical trial. JAMA. 2015; 313: 379–389.

[12] Deleris R, Bureau C, Lebbah S, Decavèle M, Dres M, Mayaux J, et al. Low dose of morphine to relieve dyspnea in acute respiratory failure: the OpiDys double-blind randomized controlled trial. Respiratory Research. 2024; 25: 280.

[13] Devlin JW, Al-Qadheeb NS, Chi A, Roberts RJ, Qawi I, Garpestad E, et al. Efficacy and safety of early dexmedetomidine during noninvasive ventilation for patients with acute respiratory failure. Chest. 2014; 145: 1204–1212.

[14] Khan BA, Perkins AJ, Khan SH, Unverzagt FW, Lasiter S, Gao S, et al. Mobile critical care recovery program for survivors of acute respiratory failure: a randomized clinical trial. JAMA Network Open. 2024; 7: e2353158.

[15] Fujishima S. Guideline-based management of acute respiratory failure and acute respiratory distress syndrome. Journal of Intensive Care. 2023; 11: 10.

[16] Wang A, Zhang M, Xiang S, Liu C. Conventional ultrasound combined with contrast-enhanced ultrasound quantitative analysis for diagnosing lung cancer metastases in neck lymph nodes. Journal of Men’s Health. 2023; 19: 70–79.

[17] Demoule A, Deleris R, Bureau C, Lebbah S, Decavèle M, Dres M, et al. Low dose of morphine to relieve dyspnea in acute respiratory failure (OpiDys): protocol for a double-blind randomized controlled study. Trials. 2022: 23: 828.

[18] Guo YL, Wang H, Chen X, Lin QQ, Zhu T, Zhang YL. Clinical characteristics and risk factors analysis for the recurrence of pelvic endodermal sinus tumors. European Journal of Gynaecological Oncology. 2023; 44: 62–70.

[19] Krewulak KD, Knight G, Irwin A, Morrissey J, Stelfox HT, Bagshaw SM, et al. Acceptability of the venting wisely pathway for use in critically ill adults with hypoxaemic respiratory failure and acute respiratory distress syndrome (ARDS): a qualitative study protocol. BMJ Open. 2024; 14: e075086.